QCIG
BSX icon

Quad-Cities Investment Group’s Boston Scientific BSX Stock Holding History

Quad-Cities Investment Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,835
Closed -$155K – 223
2019
Q3 		$155K Hold
3,835
– – 0.13% 162
2019
Q2 		$166K Sell
3,835
-115
-3% -$4.42K 0.15% 153
2019
Q1 		$155K Buy
3,950
+526
+15% +$20.1K 0.14% 155
2018
Q4 		$123K Buy
3,424
+300
+10% +$10.9K 0.13% 169
2018
Q3 		$122K Hold
3,124
– – 0.11% 190
2018
Q2 		$104K Buy
+3,124
New +$94.2K 0.1% 210

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Quad-Cities Investment Group's BSX Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 3,835 shares — an estimated $155K sold.

Quad-Cities Investment Group first reported a position in BSX in Q2 2018 and held it in 6 quarters. The position peaked at $166K in Q2 2019. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Quad-Cities Investment Group reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
  • Quad-Cities Investment Group sold 3,835 Boston Scientific shares in Q4 2019, an estimated $155K.
  • Quad-Cities Investment Group first reported a position in Boston Scientific in Q2 2018 and held it in 6 quarters.
  • Quad-Cities Investment Group's Boston Scientific position peaked at $166K in Q2 2019.
  • 853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.